Slovenija - slovenski - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

makpharm d.o.o. - klofarabin - koncentrat za raztopino za infundiranje - klofarabin 1 mg / 1 ml - klofarabin

Slovenija - slovenski - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

klofarabin - koncentrat za raztopino za infundiranje - klofarabin 1 mg / 1 ml - klofarabin

Europska Unija - slovenski - EMA (European Medicines Agency)

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - druga zdravila na živčnem sistemu - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.

Europska Unija - slovenski - EMA (European Medicines Agency)

astrazeneca ab - moxetumomab pasudotox - leukemija, dlakasta celica - antineoplastična sredstva - lumoxiti as monotherapy is indicated for the treatment of adult patients with relapsed or refractory hairy cell leukaemia (hcl) after receiving at least two prior systemic therapies, including treatment with a purine nucleoside analogue (pna).

Europska Unija - slovenski - EMA (European Medicines Agency)

amgen europe bv - sotorasib - karcinom, pljučni pljuč - antineoplastična sredstva - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.

Slovenija - slovenski - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

trabektedin - prašek za koncentrat za raztopino za infundiranje - trabektedin 0,25 mg / 1 viala - trabektedin

Slovenija - slovenski - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

trabektedin - prašek za koncentrat za raztopino za infundiranje - trabektedin 1 mg / 1 viala - trabektedin

Europska Unija - slovenski - EMA (European Medicines Agency)

swedish orphan biovitrum ab - loncastuximab tesirine - lymphoma, large b-cell, diffuse; lymphoma, b-cell - antineoplastična sredstva - zynlonta as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl), after two or more lines of systemic therapy.

Europska Unija - slovenski - EMA (European Medicines Agency)

plusultra pharma gmbh - sirolimus - angiofibroma; tuberous sclerosis - hyftor is indicated for the treatment of facial angiofibroma associated with tuberous sclerosis complex in adults and paediatric patients aged 6 years and older.

Europska Unija - slovenski - EMA (European Medicines Agency)

stemline therapeutics b.v. - elacestrant - neoplazme dojke - endokrini terapija - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.